Alternatives to Oculis Pharmaceuticals
Oculis Pharmaceuticals is a Biotechnology tool: global biopharmaceutical company developing breakthrough treatments for ophthalmic and neuro-ophthalmic conditions. Here are the 55 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotechnology companies to Oculis Pharmaceuticals
EximoreNot ratedBiopharmaceutical company developing innovative punctal plug technology for eye disease therapies.
InfinimmuneNot ratedDeveloping human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
MironidNot ratedBiopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).
Ray TherapeuticsNot ratedPioneering vision restoration therapies for severe retinal degenerations.
ONCOMATRYXNot ratedDeveloping Quantum ADCs against the tumor microenvironment for innovative cancer therapies.
Signadori BioNot ratedDeveloping a next-generation, off-the-shelf, in vivo engineered monocyte immunotherapy platform for solid tumors.
Moderna2.5 out of 5 (2)Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
- JUJuno TherapeuticsNot rated
Biotechnology company focused on developing cancer immunotherapies.
Kite PharmaNot ratedBiotechnology company developing and commercializing cell therapies for cancer treatment.
CRISPR TherapeuticsNot ratedBiotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.
Degron TherapeuticsNot ratedClinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
Seaport TherapeuticsNot ratedDeveloping novel therapeutics to restore gut lymphatic function.
CellCentricNot ratedA clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.
Supernus PharmaceuticalsNot ratedBiopharmaceutical company developing and commercializing CNS disease treatments.
- CRCreate MedicinesNot rated
Developing in vivo immunotherapies for autoimmune diseases and cancer.
LifeMine Therapeutics Inc.Not ratedClinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.
EnteromeNot ratedClinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.
AdcendoNot ratedDeveloping first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.
CelerionNot ratedA global leader in clinical pharmacology and bioanalytical sciences.
Spark TherapeuticsNot ratedA biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.
Showing the next 20 closest matches. See the rest on the Oculis Pharmaceuticals profile.
Sponsored rows are paid and labelled. Advertise on this page
